Will the refusal of patent protection for Glivec^® discourage future pharmaceutical innovation in India?

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.4, 2013-07, pp. : 439-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Better protection for patentees: preliminary injunctions in the EU for pharmaceutical patent matters

By von Falck Andreas Gundt Miriam

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 291-293

Future Science

Access to resources Recommend Favorite

Strategies for Strengthening Patent Protection of Pharmaceutical Inventions in Light of Federal Court Decisions

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1929-1936

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical patent litigation in Europe

By Cook T.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1937-1949

Bentham Science Publishers

Access to resources Recommend Favorite

The cost of pharmaceutical innovation to patients

By Keyhani Salomeh Ross Joseph S

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite